MedCap Forum

Bionaturis Group growth, in the MedCap Forum

Bionaturis Group takes part one more year in the Small and Medium-Size Companies Forum -MedCap-, on May 31st and June 1st in Madrid.

Bionaturis Group CEO, Victor Infante, is the person in charge of presenting the latest milestones achieved by the company, among with we can highlight the establishment of the subsidiary BNT China Biosciences in China, the signing of a contract with the US National Institute of Environmental Health (NIEHS) and the recent acquisition of the company ZIP Solutions, that has signed a co-development and exclusive license agreement with a leading multinational company for the final development and market of Splittera® technology.

Thanks to these latest operations, Bionaturis Group continues positioning as a reference company in its area, through its four companies and two subsidiaries with presence in Europe, USA and Asia. The Group offers premium services and products for human and animal health.

In this edition of the MedCap Forum, Bionaturis Group takes part in both ‘One to One’ meetings and the Discovery Meeting, with a lecturer in the afternoon on May, 31st, available here.

About the MedCap

The 11nd MEDCAP Forum gathers the main Small and Medium Size Companies listed on the Spanish Stock Exchange Market as well as institutional investors, brokers and financial analysts. The program includes both sectorial and general round tables, as well as the possibility of holding ‘One to One’ meetings. The main goal of the event is to stimulate the liquidity and founding of these companies.

About Bionaturis Group

Bionaturis Group offers cutting-edge biotechnological drugs and services for human and animal health. Considered an international benchmark in vaccines research, the biotechnological Group which envisions a global access to health is listed on the Spanish stock exchange for SMEs (ticker BNT). In addition to this […]

May 31st, 2016|Blog english, congress, Hechos Relevantes|Comments Off|

Bionaturis Group presents its next milestones in the MedCap Forum

Bionaturis Group takes part in the Small and Medium-Size Companies Forum -MedCap- organized by Bolsas y Mercados Españoles (BME) in Madrid on May, 27-28. The Company’s CEO, Victor Infante, is the person in charge of presenting to investors and economic analysts the consolidation of the Group’s business development and the main milestones in the short and medium term: the capital increase, the acquisition of a pharmaceutical lab CMO in Spain, the setting of the Chinese subsidiary, the expansion in Latam and USA, as well as the development of the current business in Bionaturis and BBD BioPhenix.
According to that, it is worth noting that the planned organic and inorganic growth leads to the Group’s further strengthening, which will employ around 60 people and could reach €9,7 million in revenue in 2016. Alongside this acquisition, the remaining operations will contribute to its development, diversification and integration in the value chain.
The Bionaturis Group discovery meeting session for investors and analysts is hold today Wednesday, 27 at 17.30 in the Madrid Stock Exchange headquarters (Palacio de la Bolsa). If you want to read the Relevant Info and the presentation, please, click here.
About the MedCap
The 11th MEDCAP Forum gathers the main Small and Medium Size Companies listed on the Spanish Stock Exchange Market as well as institutional investors, brokers and financial analysts. The program includes both sectorial and general round tables, as well as the possibility of holding ‘One to One’ meetings. The main goal of the event is to stimulate the liquidity and founding of these companies.
About Bionaturis Group
The Bionaturis Group offers cutting-edge biotechnological products and services for human and animal health. Considered an international benchmark in the vaccines research, Bionaturis Group closed last exercise with a sales […]

May 27th, 2015|Blog english, Hechos Relevantes|Comments Off|

Bionaturis takes part in the MedCap Forum

As previous years Bionaturis (ticker BNT) will take part in the Medium Capitalization Companies Forum, organized by Bolsas y Mercados Españoles (BME) that celebrates on 27 and 28 May its tenth edition. This meeting has the aim of  fostering the liquidity and financial standing of these companies that are listed on Spanish Stock Markets.

Our CEO, Víctor Infante, will represent Bionaturis at the  private meetings  with investors that will take place in the Palacio de la Bolsa (Madrid). Infante has stated: “Meetings like these are very useful to keep a direct contact with our current and future investors, and other companies listed on financial markets as well. It´s a good opportunity for the MAB to show off its outstanding progression”.

Besides Bionaturis, the MAB will be represented by other top-perform companies such as Carbures and Gowex, among others.

For further information, please click here

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

CERRAR